These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11929818

  • 1. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
    Harada H, Hiraoka M, Kizaka-Kondoh S.
    Cancer Res; 2002 Apr 01; 62(7):2013-8. PubMed ID: 11929818
    [Abstract] [Full Text] [Related]

  • 2. A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth.
    Yu Z, Wu J, Wu S, Jia P, Tong Y, Wu X, Wang Y.
    Cancer Lett; 2009 Jun 28; 279(1):101-7. PubMed ID: 19232460
    [Abstract] [Full Text] [Related]

  • 3. Significance of HIF-1-active cells in angiogenesis and radioresistance.
    Harada H, Kizaka-Kondoh S, Li G, Itasaka S, Shibuya K, Inoue M, Hiraoka M.
    Oncogene; 2007 Nov 29; 26(54):7508-16. PubMed ID: 17563752
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
    Koshikawa N, Takenaga K.
    Cancer Res; 2005 Dec 15; 65(24):11622-30. PubMed ID: 16357173
    [Abstract] [Full Text] [Related]

  • 5. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T.
    Cancer Res; 2007 May 01; 67(9):4157-63. PubMed ID: 17483326
    [Abstract] [Full Text] [Related]

  • 6. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S, Itasaka S, Zeng L, Tanaka S, Zhao T, Takahashi Y, Shibuya K, Hirota K, Semenza GL, Hiraoka M.
    Clin Cancer Res; 2009 May 15; 15(10):3433-41. PubMed ID: 19417024
    [Abstract] [Full Text] [Related]

  • 7. The kinetics and tissue distribution of protein transduction in mice.
    Cai SR, Xu G, Becker-Hapak M, Ma M, Dowdy SF, McLeod HL.
    Eur J Pharm Sci; 2006 Mar 15; 27(4):311-9. PubMed ID: 16376528
    [Abstract] [Full Text] [Related]

  • 8. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG, Ghafar MA, Salomon L, Vacherot F, Benedit P, Chen MW, Shabsigh A, Burchardt M, Chopin DK, Shabsigh R, Buttyan R.
    J Cancer Res Clin Oncol; 2002 Jul 15; 128(7):358-62. PubMed ID: 12136249
    [Abstract] [Full Text] [Related]

  • 9. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
    Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J, Choi S, Jung CR, Im DS.
    Mol Ther; 2004 Nov 06; 10(5):938-49. PubMed ID: 15509511
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transduction of functionally active TAT fusion proteins into cornea.
    Guo X, Hutcheon AE, Zieske JD.
    Exp Eye Res; 2004 May 06; 78(5):997-1005. PubMed ID: 15051480
    [Abstract] [Full Text] [Related]

  • 14. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Ai Zheng; 2004 Jul 06; 23(7):788-93. PubMed ID: 15248913
    [Abstract] [Full Text] [Related]

  • 15. TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy.
    Zheng R, Yao Q, Xie G, Du S, Ren C, Wang Y, Yuan Y.
    Oncotarget; 2015 Jul 10; 6(19):17417-29. PubMed ID: 26025927
    [Abstract] [Full Text] [Related]

  • 16. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 10; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice.
    Serganova I, Doubrovin M, Vider J, Ponomarev V, Soghomonyan S, Beresten T, Ageyeva L, Serganov A, Cai S, Balatoni J, Blasberg R, Gelovani J.
    Cancer Res; 2004 Sep 01; 64(17):6101-8. PubMed ID: 15342393
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions.
    Zeng L, Kizaka-Kondoh S, Itasaka S, Xie X, Inoue M, Tanimoto K, Shibuya K, Hiraoka M.
    Cancer Sci; 2007 Sep 01; 98(9):1394-401. PubMed ID: 17608771
    [Abstract] [Full Text] [Related]

  • 20. The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
    Harada H, Kizaka-Kondoh S, Itasaka S, Shibuya K, Morinibu A, Shinomiya K, Hiraoka M.
    Biochem Biophys Res Commun; 2007 Sep 07; 360(4):791-6. PubMed ID: 17624305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.